Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.58 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.56 |
| ▸ | RXRA | P19793 | 1/20 | 0.56 |
| ▸ | RXRB | P28702 | 1/20 | 0.56 |
| ▸ | RXRG | P48443 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8935369 | 0.86 | FFAR1 (0.57) | MAOBMAOAFFAR1RXRARXRB | |
| SCHEMBL27323062 | 0.82 | MAOB (0.52) | MAOBMAOAFFAR1RXRARXRB | |
| SCHEMBL9626469 | 0.82 | MAOB (0.66) | MAOBMAOAFFAR1RXRARXRB | |
| SCHEMBL1070558 | 0.81 | MAOB (0.56) | MAOBMAOAFFAR1RXRARXRB | |
| SCHEMBL21234325 | 0.80 | MAOB (0.67) | MAOBMAOAFFAR1RXRARXRB | |
| SCHEMBL13946908 | 0.80 | MAOB (0.60) | MAOBMAOAFFAR1RXRARXRB | |
| SCHEMBL7395373 | 0.79 | F2 (0.58) | MAOBMAOAFFAR1RXRARXRB | |
| SCHEMBL8935373 | 0.79 | PKM (0.57) | MAOBMAOAFFAR1RXRARXRB | |
| SCHEMBL7398313 | 0.79 | MAOB (0.62) | MAOBMAOARXRARXRBRXRG | |
| Hydrochloric Acid SCHEMBL8935265 | 0.78 | MAOB (0.63) | MAOBMAOARXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5502079-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | FARMITALIA CARLO ERBA S.R.L. (IT) | 1996-03-26 | — | — | US | disclosed |